Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethanol + glycolic acid is a combination of two small molecules, ethanol (an alcohol) and glycolic acid (an alpha hydroxy acid). Ethanol is commonly used as an antiseptic and as an antidote for methanol and ethylene glycol poisoning by inhibiting alcohol dehydrogenase, thereby preventing the formation of toxic metabolites[3][5]. Glycolic acid is primarily used as a keratolytic agent in dermatology due to its ability to promote exfoliation of the skin; it also acts as a metabolite in various biochemical pathways[1][2]. The combination has been investigated for topical use, such as in the treatment of cold sores, where it may provide both antiviral effects (from ethanol) and enhanced skin penetration or exfoliation (from glycolic acid)[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ethanol + glycolic acid.